DNA methylation is a fundamental epigenetic modification involved in various biological processes and diseases. Analysis of DNA methylation data at a genome-wide and high …
P Ajithkumar, SS Vasantharajan, S Pattison… - International journal of …, 2024 - mdpi.com
Metastatic progression is a complex, multistep process and the leading cause of cancer mortality. There is growing evidence that emphasises the significance of epigenetic …
Next-generation sequencing (NGS) studies have demonstrated that co-occurring sporadic endometrioid endometrial carcinoma (EEC) and endometrioid ovarian carcinoma (EOC) are …
T Draškovič, B Ranković, N Zidar, N Hauptman - Clinical Epigenetics, 2024 - Springer
Background DNA methylation biomarkers are one of the most promising tools for the diagnosis and differentiation of adenocarcinomas of the liver, which are among the most …
Globally, colorectal cancer (CRC) is the third most frequently occurring cancer. Progression on to an advanced metastatic malignancy (metCRC) is often indicative of poor prognosis, as …
P Ajithkumar, G Gimenez, PA Stockwell, S Almomani… - Data, 2023 - mdpi.com
Sequencing-based genome-wide DNA methylation, gene expression studies and associated data on paired colorectal cancer (CRC) primary and liver metastasis are very …
EJ Rodger, PA Stockwell, S Almomani, MR Eccles… - STAR protocols, 2023 - Elsevier
Aberrant DNA methylation is a universal feature of cancer. Here, we present a protocol for generating high-quality genome-scale DNA methylation sequencing data from a variety of …
R Banerjee, P Ajithkumar, N Keestra, J Smith… - Cancers, 2024 - mdpi.com
Simple Summary Contrary to the conventional understanding of DNA hypermethylation suppressing gene expression, a new mechanism emerges, suggesting that high methylation …
J Smith, P Ajithkumar, EJ Wilkinson, A Dutta… - Data, 2024 - mdpi.com
Prostate cancer (PCa) is a major health burden worldwide, and despite early treatment, many patients present with biochemical recurrence (BCR) post-treatment, reflected by a rise …